Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07377682

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

Observational Prospective Study in Patients With Major Depressive Disorder and Mild Cognition Impairment Treated With Trazodone in a Real-world Setting (TRACOMDD)

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A · Industry
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

TRACOMDD study is a study with the intention to describe the real-world use of trazodone and the clinical response in a sub-group of patients affected by Major Depressive Disorder and Mild Cognitive impairment, by collecting data from standard clinical practice in Italy, Poland, and Romania

Conditions

Timeline

Start date
2025-12-15
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2026-01-30
Last updated
2026-01-30

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07377682. Inclusion in this directory is not an endorsement.

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania (NCT07377682) · Clinical Trials Directory